Clarivate PLC

Análisis de la acción Clarivate PLC (CLVT)

$2.020

-0.010 (-0.49%)Al cierre

Loading chart…
High
2.060
Open
2.030
VWAP
2.02
Vol
2.95M
Mkt Cap
3.81B
Low
1.980
Amount
5.96M
EV/EBITDA, TTM
6.10

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. It operates through three segments, which include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users around the world. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. The Life Sciences & Healthcare segment offers life sciences and healthcare organizations with the contextual intelligence needed to deliver safe and commercial treatments and solutions to patients.

clarivate.com

AI analysis of Clarivate PLC (CLVT)

buy

Clarivate PLC (CLVT) appears to be a good buy right now due to its current price of $2.02 being significantly lower than the analyst price target of $5. Additionally, the forward P/E ratio of 2.7263 indicates potential for future earnings growth. The recent insider purchase of approximately 900,000 shares at $1.86 suggests strong confidence in the company's recovery, despite a 52% decline in stock price over the past year. However, the main risk is the company's net income loss of $268.6 million in Q2 2026, indicating ongoing profitability challenges.

Métricas de valoración

The current forward P/E ratio for Clarivate PLC (CLVT) is 2.73, compared to its 5-year average forward P/E of 10.94.

Forward P/E

Undervalued
5Y Average P/E
10.94
Current P/E
2.73
Sobrevalorada
17.56
Infravalorada
4.31

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
16.54
Current EV/EBITDA
6.10
Sobrevalorada
34.22
Infravalorada
-1.14

Forward P/S

Undervalued
5Y Average P/S
2.22
Current P/S
0.64
Sobrevalorada
3.75
Infravalorada
0.70

Alphio AI Price Scenarios for CLVT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CLVT

$5.42

Precio del escenario

B

Base

Base · 50%CLVT

$4.71

Precio del escenario

B

Bear

Bear · 25%CLVT

$4.31

Precio del escenario

Whales holding CLVT

I

Invenomic Capital Management LP

+ HoldingCLVT

+14.54%

3M Return

L

Lingotto Investment Management LLP

+ HoldingCLVT

+5.04%

3M Return

B

BW Gestao de Investimentos Ltda.

+ HoldingCLVT

-0.51%

3M Return

Cronología de eventos

2026-07-29 (ET)

06:30:00

Clarivate Reports Q2 Revenue of $587.3M

06:30:00

Clarivate Maintains FY26 Revenue Outlook at $2.3B to $2.42B

06:30:00

Clarivate Appoints Michael Easton as CFO

2026-07-14 (ET)

05:30:00

Clarivate Selected to Modernize France's National Academic Library System

2026-07-06 (ET)

16:30:00

Major Averages Open Higher as Chip Stocks Rebound

Noticias

CLVT FAQ — answered by Alphio AI

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. It operates through three segments, which include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users around the world. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. The Life Sciences & Healthcare segment offers life sciences and healthcare organizations with the contextual intelligence needed to deliver safe and commercial treatments and solutions to patients. It operates in the Industrials sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

Clarivate PLC (CLVT) appears to be a good buy right now due to its current price of $2.02 being significantly lower than the analyst price target of $5. Additionally, the forward P/E ratio of 2.7263 indicates potential for future earnings growth. The recent insider purchase of approximately 900,000 shares at $1.86 suggests strong confidence in the company's recovery, despite a 52% decline in stock price over the past year. However, the main risk is the company's net income loss of $268.6 million in Q2 2026, indicating ongoing profitability challenges.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis